4-NITROBENZYL (R)-4-((2R,3S)-3-((R)-1-((TERT-BUTYLDIMETHYLSILYL)OXY)ETHYL)-4-OXO-2-AZETIDINYL)-3-OXOPENTANOATE
UNII LHK8YF9ZU9

Substance Identification & Data

This profile provides standardized clinical and technical data for 4-nitrobenzyl (r)-4-((2r,3s)-3-((r)-1-((tert-butyldimethylsilyl)oxy)ethyl)-4-oxo-2-azetidinyl)-3-oxopentanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LHK8YF9ZU9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 90822-22-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

LHK8YF9ZU9

CAS Registry Number

90822-22-3

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

4-NITROBENZYL (R)-4-((2R,3S)-3-((R)-1-((TERT-BUTYLDIMETHYLSILYL)OXY)ETHYL)-4-OXO-2-AZETIDINYL)-3-OXOPENTANOATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C23H34N2O7Si

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ANRSPPUCDKCRMR-REABXYAWSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

14286210

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@@H](C(CC(OCc1ccc([N+](=O)[O-])cc1)=O)=O)(C)[C@@]2([C@@]([C@H](O[Si](C(C)(C)C)(C)C)C)(C(=O)N2)[H])[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 4-nitrobenzyl (r)-4-((2r,3s)-3-((r)-1-((tert-butyldimethylsilyl)oxy)ethyl)-4-oxo-2-azetidinyl)-3-oxopentanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(4-NITROPHENYL)METHYL (.GAMMA.R,2R,3S)-3-((1R)-1-(((1,1-DIMETHYLETHYL)DIMETHYLSILYL)OXY)ETHYL)-.GAMMA.-METHYL-.BETA.,4-DIOXO-2-AZETIDINEBUTANOATE

SYS

(R)-4-NITROBENZYL 4-((2R,3S)-3-((R)-1-((TERT-BUTYLDIMETHYLSILYL)OXY)ETHYL)-4-OXOAZETIDIN-2-YL)-3-OXOPENTANOATE

SYS

2-AZETIDINEBUTANOIC ACID, 3-((1R)-1-(((1,1-DIMETHYLETHYL)DIMETHYLSILYL)OXY)ETHYL)-.GAMMA.-METHYL-.BETA.,4-DIOXO-, (4-NITROPHENYL)METHYL ESTER, (.GAMMA.R,2R,3S)-

SYS

2-AZETIDINEBUTANOIC ACID, 3-(1-(((1,1-DIMETHYLETHYL)DIMETHYLSILYL)OXY)ETHYL)-.GAMMA.-METHYL-.BETA.,4-DIOXO-, (4-NITROPHENYL)METHYL ESTER, (2R-(2.ALPHA.(R*),3.BETA.(R*)))-

SYS

4-NITROBENZYL (R)-4-((2R,3S)-3-((R)-1-((TERT-BUTYLDIMETHYLSILYL)OXY)ETHYL)-4-OXO-2-AZETIDINYL)-3-OXOPENTANOATE

SYS

External Clinical & Regulatory Resources

Previous UNIILHK3UX2AXP

Next UNIILHL6L5CXG8